Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.0689
+0.0039 (6.00%)
May 26, 2026, 3:48 PM EST
PVCT Market Cap
PVCT has a market cap or net worth of $27.32 million as of May 27, 2026. Its market cap has decreased by -32.01% in one year.
Market Cap
27.32M
Enterprise Value
29.87M
Revenue
57.48K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since April 24, 2002, PVCT's market cap has increased from 4.32K to 27.32M, an increase of 631,972.93%. That is a compound annual growth rate of 43.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 27.32M | 16.28% |
| Dec 31, 2025 | 23.49M | -53.46% |
| Dec 31, 2024 | 50.48M | 25.33% |
| Dec 29, 2023 | 40.27M | -11.35% |
| Dec 30, 2022 | 45.43M | 96.93% |
| Dec 31, 2021 | 23.07M | -1.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuo Therapeutics | 53.58M |
| Vicapsys Life Sciences | 47.26M |
| Oncotelic Therapeutics | 25.74M |
| Arch Biopartners | 21.74M |
| Anebulo Pharmaceuticals | 18.76M |
| ZIVO Bioscience | 16.42M |
| Galera Therapeutics | 16.06M |
| Zeo ScientifiX | 15.40M |